Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial
Tadej Battelino
◽
Ramin Tehranchi
◽
Timothy Bailey
◽
Klemen Dovc
◽
Anita Melgaard
◽
...
2021 ◽
Vol 116
◽
pp. 154507
Tadej Battelino
◽
Ramin Tehranchi
◽
Timothy Bailey
◽
Klemen Dovc
◽
Anita Melgaard
◽
...
2003 ◽
Vol 4
(2)
◽
pp. 82-86
◽
Richard C. Eastman
◽
Amy D. Leptien
◽
H. Peter Chase
2019 ◽
Vol 21
(11)
◽
pp. 627-634
◽
Christos Chatzakis
◽
Dimitrios Floros
◽
Maria Papagianni
◽
Kyriaki Tsiroukidou
◽
Konstantina Kosta
◽
...
2014 ◽
Vol 54
(2)
◽
pp. S41
◽
2006 ◽
Vol 32
(2)
◽
pp. 159-165
◽
CL Gay
◽
F Chapuis
◽
N Bendelac
◽
F Tixier
◽
S Treppoz
◽
...
2021 ◽
Vol Volume 13
◽
pp. 1-10
Nicholas Bari Ndahura
◽
Judith Munga
◽
Judith Kimiywe
◽
Ezekiel Mupere
2016 ◽
Vol 4
(1)
◽
pp. e000165
◽
Deborah Christie
◽
Rebecca Thompson
◽
Mary Sawtell
◽
Elizabeth Allen
◽
John Cairns
◽
...
2020 ◽
Vol 43
(7)
◽
pp. 1512-1519
◽
Thomas Danne
◽
William V. Tamborlane
◽
Oleg A. Malievsky
◽
Denise R. Franco
◽
Tomoyuki Kawamura
◽
...
2019 ◽
Vol 68
(Supplement 1)
◽
pp. 351-OR
HELEN R. MURPHY
◽
DENICE FEIG
◽
NASHITA PATEL
2020 ◽
Vol 43
(9)
◽
pp. 2281-2288
◽
Angela S. Lee
◽
Nathan A. Johnson
◽
Margaret J. McGill
◽
Jane Overland
◽
Connie Luo
◽
...
Close
Export Citation Format
Close
Share Document
Close